No. Pages : 124 Published Date: 30-Jun-2015

The Asia-Pacific IVF market would exhibit a notable growth during the forecast period, primarily due to factors such as delayed pregnancies, rising infertility rates due to dysfunctional lifestyles and the emergence of newer fertility tourism destinations. Other factors that would propel the market growth are rising technological advancements, use of intra- cytoplasmic sperm injection (ICSI) and donor egg IVF methods, which collectively boost the success rates of conventional IVF cycles. High costs associated with the treatments, inadequate IVF reimbursements, low health awareness specifically in under-developed Asia-Pacific regions such as Nepal, Myanmar and other ethical concerns are factors that would restrain the market growth. The Asia-Pacific IVF market is estimated to garner $4 billion by 2021, registering a CAGR of 13.5% from 2015 to Report Description

The commercialization of cost-efficient treatments and the emerging role of medical tourism, mainly in developing nations across Asia- Pacific countries would offer lucrative growth opportunities in future. Further, growing clinical research initiatives for the development of novel IVF technologies would provide a dynamic platform for growth of the Asia-Pacific IVF market. To provide a detailed market assessment, the report segments the Asia-Pacific IVF market on the basis of number of IVF cycles, end- users and a country level analysis. The end-users market is categorized into fertility clinics, hospitals, surgical centres and clinical research institutes. Fertility clinics and hospitals were the leading end-user segments, accounting for about 5/6th of the market, in Report Description

Geographically, the Asia-Pacific IVF market is segmented across India, China, Japan, Australia, New-Zealand, Korea, Thailand and other Asia- Pacific countries. In terms of revenue generation, China dominates the Asia-Pacific IVF market, owing to the rapid adoption of advanced technologies and availability of skilled workforce. However, the IVF market value, in India, is set to register a promising CAGR of 15.3% from 2015 to This growth is largely supplemented by factors such as the rising trend of fertility tourism and wide availability of IVF clinics. In terms of number of cycles performed, China is the leading country accounting for a majority of the market share and is expected to maintain its market position throughout the analysis period. However, the India IVF market, in terms of number of cycles performed, would register a promising CAGR of 13.2% during 2015 to Report Description

 The report provides an in-depth analysis on the Asia-Pacific IVF market across seven major countries with a cross sectional analysis of the total number of IVF cycles performed, and the total revenue generated during the forecast period  The report helps in understanding the strategies adopted by various IVF clinics and hospitals in major countries, in order to capitalize on opportunities in the Asia-Pacific IVF market  The report comprehensively analyzes the market scenario across different countries in the Asia Pacific region  The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2014–2021, in terms of value and volume Key Market Benefits

Asia-Pacific IVF Market – By End Users (Value and Volume) Key Market Segments Fertility ClinicsHospitalsSurgical centersClinical research institutes

IVF Market – By Geography China Australia India Japan Other

Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Asia-pacific In-vitro Fertilization (Ivf) Market Overview Chapter 4 Asia-pacific Ivf Market (Revenue And Number Of Cycles) Table of Contents

FOR MORE DETAILS Visit us at : market Stay With Us: TELEPHONE: